BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

MicrofluidX and Immatics working together on automated end-to-end bioprocessing for TCR-T therapies

MicrofluidX, a UK-based provider of next generation bioreactors for cell biology research and cell therapy manufacturing, today announces a joint research ...

May 03, 2023 | News

Astellas Enters Into Definitive Agreement to Acquire Iveric Bio

-Lead Program, Avacincaptad Pegol for the Potential Treatment of Geographic Atrophy with PDUFA Goal Date of August 19, 2023- -Acquisition advances A...

May 01, 2023 | News

Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2023

–Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organ...

May 01, 2023 | News

OBiO and CHINAGENE to provide gene therapy commercial manufacturing services under strategic agreement.

"This agreement signed by OBiO and CHINAGENE is a continuation and sublimation from previous cooperation," Guodong Jia, CEO of OBiO said, "CHINAGENE i...

April 30, 2023 | News

Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China

CTH-004 has shown promising results in animal models of ovarian cancer and will be evaluated in a clinical trial under a research and development...

April 28, 2023 | News

Exothera Forms Partnership with Quantoom Biosciences to Launch RNA Business Unit

Exothera has partnered with Quantoom Biosciences ("Quantoom") to gain access to Quantoom’s Nfinity technology, a continuous production platform for R...

April 27, 2023 | News

MGI Announces New Customer Experience Center in South Korea with BMS

"Genomics is an exploding and popular field in South Korea, and we at MGI are excited to join hands with BMS to welcome researchers and partners in th...

April 27, 2023 | News

Agilent and Theragen Bio Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea

Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to ...

April 26, 2023 | News

I-Mab Announces Positive Outcome in Arbitration Relating to Agreements with Tracon

Award is an important victory for I-Mab and its shareholders on multiple levels, ending the multi-year long dispute Tribunal completely denied Tracon's ...

April 26, 2023 | News

Merck Launches Ultimus® Film to Offer Superior Strength and Leak Resistance in Single-use Assemblies

Cutting-edge technology now available in Mobius® 3D process containers Provides 10 times greater abrasion resistance compared to other single-u...

April 25, 2023 | News

2,800 Singapore Students to Benefit from new STEM Partnership

Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) today announced an inaugural partnership with the Science Centre Board to ins...

April 25, 2023 | News

Twist Bioscience and Astellas Collaborate for Antibody Discovery in Immunotherapy

-Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

April 24, 2023 | News

Everest Medicines Launches First-in-Disease Therapy for IgA Nephropathy in China's Hainan Boao Pilot Zone.

The launch of this early-access program in Hainan marks the beginning of a new treatment era for IgA nephropathy in China, where Everest can...

April 24, 2023 | News

Bridge Biotherapeutics Receives FDA Approval for First-in-Human Study of BBT-207, a 4th Gen EGFR TKI.

The company has been notified by the FDA that the Phase 1/2 clinical trial may proceed The latest preclinical data explored the antitumor effica...

April 24, 2023 | News

Stay Connected